Profund Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389K | Sell |
26,253
-4,025
| -13% | -$59.6K | 0.01% | 556 |
|
|
2025
Q1 | $543K | Sell |
30,278
-3,803
| -11% | -$68.2K | 0.02% | 444 |
|
|
2024
Q4 | $594K | Buy |
34,081
+15,181
| +80% | +$264K | 0.02% | 429 |
|
|
2024
Q3 | $264K | Sell |
18,900
-14,936
| -44% | -$209K | 0.01% | 873 |
|
|
2024
Q2 | $278K | Sell |
33,836
-57,898
| -63% | -$476K | 0.01% | 764 |
|
|
2024
Q1 | $707K | Buy |
91,734
+22,247
| +32% | +$172K | 0.03% | 459 |
|
|
2023
Q4 | $625K | Buy |
69,487
+8,504
| +14% | +$76.5K | 0.03% | 448 |
|
|
2023
Q3 | $545K | Sell |
60,983
-28,947
| -32% | -$259K | 0.03% | 444 |
|
|
2023
Q2 | $1.38M | Buy |
89,930
+29,401
| +49% | +$452K | 0.07% | 234 |
|
|
2023
Q1 | $1.36M | Buy |
+60,529
| New | +$1.36M | 0.08% | 207 |
|